Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue SUPPL. 1, 1996, Pages 35-40

  Strano, Antonio ^a   Hoppensteadt, Debra ^b   Walenga, Jeanine M ^b   Fareed, Jawed ^b   Sabbá, Carlo ^c   Berardi, Elsa ^c   Allegra, Claudio ^d   Carlizza, Anita ^d   Binaghi, Fernando ^e   Fronteddu, Francesco ^e   Del Guercio, Raffaele ^f   Del Guercio, Michele ^f   Pinto, Antonio ^g   Alletto, Giuseppe ^h   Nazzari, Marco ⁱ   Ferrari, Pier Antonio ⁱ  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF BARI   (Italy)

^d S Giovanni Hospital   (Italy)

^e UNIVERSITY OF CAGLIARI   (Italy)

^f SECOND UNIVERSITY OF NAPLES   (Italy)

^g UNIVERSITY OF CATANIA   (Italy)

^h UNIVERSITY OF PALERMO   (Italy)

ⁱ Crinos Biological Research Laboratories   (Italy)

Author keywords

Atherosclerosis; Coagulation; Fibrinolysis; Peripheral arterial disease

Indexed keywords

ANTITHROMBIN III; DEFIBROTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYDEOXYRIBONUCLEOTIDE; PROTEIN C; PROTEIN S; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

ADULT; AGED; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION; DOUBLE-BLIND METHOD; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PERIPHERAL VASCULAR DISEASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYDEOXYRIBONUCLEOTIDES; PROGNOSIS;

EID: 9444221315     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ulutin ON: Atherosclerosis and hemostasis. Semin Thromb Hemostas 12:156-174, 1986.
2. Hamsten A, G Walldius, A Szamosi, M Blombäck, U de Faire, G Dahlen, C Landou, B Wiman: Plasminogen activator inhibitor in plasma: Risk factors for recurrent myocardial infarction. Lancet 4:3-9, 1987.
3. Nilsson TK, O Johnson: The extrinsic fibrinolytic system in survivors of myocardial infarction. Thromb Res 48:621-630, 1987.
4. Gram J, C Kluft, J Jespersen: Depression of t-PA activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI). Thromb Haemostas 58: 817-821, 1987.
5. Almer LO, H Oehlin: Elevated levels of the rapid inhibitor of plasminogen activator (tPAI) in acute myocardial infarction. Thromb Res 47:335-339, 1987.
6. Hartl D, E Tiso, K Anderle, A Philapitsch, G Anger: Reduced fibrinolytic potential in patients with arterial occlusive disease (AOD) in comparison with normal subjects. Hemostasis 18(Suppl 1):93-98, 1988.
7. Earnshaw JJ, JC Westby, BR Hopkinson, GS Makin: Resting plasma fibrinolytic activity and fibrinolytic potential in peripheral vascular disease. J Cardiovasc Surg 29:300-305, 1988.
8. Speiser W, P Speiser, E Minar, C Korninger, H Niessner, K Huber, G Schernthaner, H Ehringer, K Lechner: Activation of coagulation and fibrinolysis in patients with arteriosclerosis: Relation to localization of vessel disease and risk factors. Thromb Res 59:77-88, 1990.
9. Bertelé V, L Mussoni, G del Rosso, G Pintucci, MP Carriero, MG Merati, A Libretti, G de Gaetano: Defective fibrinolytic response in atherosclerotic patients - effect of iloprost and its possible mechanism of action. Thromb Haemostas 60:141-144, 1988.
10. Strano A, J Fareed, C Sabbá, O Albano, C Allegra, A Carlizza, F Binaghi, F Fronteddu, R del Guercio, MR Arpaia, A Pinto, G Alletto, JM Walenga, D Hoppensteadt, M Nazzari, PA Ferrari: A double blind, multicenter, placebo-controlled, dose comparison study of orally administered defibrotide: Preliminary results in patients with peripheral arterial disease. Semin Thromb Hemostas 17(Suppl 2):228-234, 1991.
11. Coccheri S, G Biagi, C Legnani, B Bianchini, F Grauso: Acute effects of defibrotide - an experimental antithrombotic agent - on fibrinolysis and blood prostanoids in man. Eur J Clin Pharmacol 35:151-156, 1988.
12. Criqui MH, A Fronek, MR Klauber, E Barret-Connor, S Gabriel: The sensitivity, specificity and predictive value of traditional clinical evaluation of peripheral arterial disease - results from non-invasive testing in a defined population. Circulation 71:516-522, 1985.
13. McKenna M, S Wolfson, L Kuller: The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87:119-128, 1991.
14. Brevetti G, M Chiariello, G Ferulano, A Policicchio, A Nevola, A Rossini, T Attisano, G Ambrosio, N Siliprandi, C Angelini: Increase in walking distance in patients with peripheral vascular disease treated with L-carnitine: A double blind cross-over study. Circulation 77:767-773, 1988.
15. Strano A, C Allegra, J Walenga, D Hoppensteadt, J Fareed: Effect of defibrotide in peripheral arterial disease (POAD): Preliminary results of a multicenter trial. In: Strano A, S Novo (Eds): Advances in Vascular Pathology 1990. Vol. 3. Proceedings of the 15th World Congress of the International Union of Angiology. Elsevier Science Amsterdam, 1989, pp 153-156.
16. Tohgi H, M Kawashima, K Tamura, H Suzuki: Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Stroke 21:1663-1667, 1990.
17. Takano K, T Yamaguchi, H Kato, T Omae: Activation of coagulant in acute cardioembolic stroke. Stroke 22:12-16, 1991.
18. D'Angelo A, G Landi, S Viganó-D'Angelo, E Nobile Orazio, E Boccardi, L Candelise, PM Mannucci: Protein C in acute stroke. Stroke 19:579-583, 1988.
19. Cariello A, A Quatraro, P Dello Russo, E Marchi, M Barbanti, MR Milani, D Giugliano: Protein C deficiency in insulin-dependent diabetes a hyperglycemia-related phenomenon. Thromb Hemostas 64:104-107, 1990.
20. Saito M, I Kumabashiri, H Jokaji, H Asakura, C Uotani, M Ostsuka, M Hamada, M Tatsumura, K Morinaga, T Matsuda: The levels of P-C and P-S in plasma in patients with type II diabetes mellitus. Thromb Res 52:479-486, 1988.
21. Gensini GF, C Rostagno, R Abbate, S Favilla, PM Mannucci, GG Neri Serneri: Increased protein C and fibrinopeptide A concentration in patients with angina. Thromb Res 50:517-525, 1988.